(S)-4,11-Dihydroxy-2-methyl-5,10-dioxo-N-(pyrrolidin-3-yl)-1H-naphtho[2,3-f]indole-3-carboxamide

ID: ALA4788358

PubChem CID: 162669522

Max Phase: Preclinical

Molecular Formula: C22H19N3O5

Molecular Weight: 405.41

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1[nH]c2c(O)c3c(c(O)c2c1C(=O)N[C@H]1CCNC1)C(=O)c1ccccc1C3=O

Standard InChI:  InChI=1S/C22H19N3O5/c1-9-13(22(30)25-10-6-7-23-8-10)14-17(24-9)21(29)16-15(20(14)28)18(26)11-4-2-3-5-12(11)19(16)27/h2-5,10,23-24,28-29H,6-8H2,1H3,(H,25,30)/t10-/m0/s1

Standard InChI Key:  LPFPHLLFVCQNCX-JTQLQIEISA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
    1.6949  -11.3663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6937  -12.1859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4018  -12.5949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4000  -10.9575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1086  -11.3628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1074  -12.1879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8175  -12.5993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8199  -10.9489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5345  -11.3648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5333  -12.1859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2426  -12.5957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2410  -10.9553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9509  -11.3614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9513  -12.1832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7330  -12.4368    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2158  -11.7717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7324  -11.1072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8199  -10.1317    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8170  -13.4165    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2387  -10.1381    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2439  -13.4129    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9845  -10.3299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7838  -10.1596    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4374   -9.7228    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0330  -11.7713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0360   -9.3823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8124   -9.1284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8120   -8.3112    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0346   -8.0590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5547   -8.7204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
  7 10  1  0
  9  8  1  0
  9 10  2  0
 10 11  1  0
 11 14  2  0
 13 12  2  0
 12  9  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
  8 18  2  0
  7 19  2  0
 12 20  1  0
 11 21  1  0
 17 22  1  0
 22 23  1  0
 22 24  2  0
 16 25  1  0
 26 23  1  1
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4788358

    ---

Associated Targets(Human)

CAPAN-1 (772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TERT-RPE1 (415 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.41Molecular Weight (Monoisotopic): 405.1325AlogP: 1.75#Rotatable Bonds: 2
Polar Surface Area: 131.52Molecular Species: BASEHBA: 6HBD: 5
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 7.67CX Basic pKa: 10.36CX LogP: 1.39CX LogD: 1.11
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.32Np Likeness Score: 0.04

References

1. Tikhomirov AS,Litvinova VA,Andreeva DV,Tsvetkov VB,Dezhenkova LG,Volodina YL,Kaluzhny DN,Treshalin ID,Schols D,Ramonova AA,Moisenovich MM,Shtil AA,Shchekotikhin AE.  (2020)  Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.,  199  [PMID:32428792] [10.1016/j.ejmech.2020.112294]

Source